Tinya J. Abrams
- Gastroenterology top 2%
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments 3
- Acute Myeloid Leukemia Research 2
- Multiple Myeloma Research and Treatments 2
- Oncology top 5%
- HER2/EGFR in Cancer Research 6
- Cancer Cells and Metastasis 3
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 2
-
- Angiogenesis and VEGF in Cancer 3
- Fibroblast Growth Factor Research 2
- Co-authors
- Lesley MurrayJulie M. CherringtonLeslie B. LeeNancy PryerBeverly D. SmolichSharianne G. LouieKevin YeeWilliam C. Manning
- Cited by
- GastroenterologyHematologyOncology
- Journals
- Cancer Research (4 papers)Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesSwitzerlandAustralia
In The Last Decade
Tinya J. Abrams
17 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Gastroenterology 254
- Hematology 415
- Oncology 835
- Pulmonary and Respiratory Medicine 824
- Cancer Research 322
Countries citing papers authored by Tinya J. Abrams
This map shows the geographic impact of Tinya J. Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tinya J. Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tinya J. Abrams more than expected).
Fields of papers citing papers by Tinya J. Abrams
This network shows the impact of papers produced by Tinya J. Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tinya J. Abrams. The network helps show where Tinya J. Abrams may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tinya J. Abrams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 1 | |
| 2 | 2018 | 18 | |
| 3 | 2018 | 29 | |
| 4 | 2015 | 2 | |
| 5 | 2015 | 8 | |
| 6 | 2013 | 1 | |
| 7 | 2012 | 49 | |
| 8 | 2012 | 57 | |
| 9 | 2011 | 1 | |
| 10 | 2006 | 53 | |
| 11 | 2004 | 62 | |
| 12 | Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer. | 2003 | 215 |
| 13 | 2003 | 254 | |
| 14 | 2003 | 84 | |
| 15 | SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer.breakdown → | 2003 | 549 |
| 16 | SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivobreakdown → | 2003 | 703 |
| 17 | Changes in the parous rat mammary gland environment are involved in parity-associated protection against mammary carcinogenesis. | 1999 | 28 |
About Tinya J. Abrams
Tinya J. Abrams is a scholar working on Hematology, Oncology, Gastroenterology, Molecular Biology and Cancer Research, having authored 17 papers that have together received 2.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Chronic Myeloid Leukemia Treatments (3 papers), Cancer Cells and Metastasis (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Acute Myeloid Leukemia Research (2 papers), Fibroblast Growth Factor Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Gastroenterology (254 citations), Hematology (415 citations), Oncology (835 citations), Pulmonary and Respiratory Medicine (824 citations) and Cancer Research (322 citations). Tinya J. Abrams has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Lesley Murray, Julie M. Cherrington, Leslie B. Lee, Nancy Pryer, Beverly D. Smolich, Sharianne G. Louie, Kevin Yee, William C. Manning, Ajia Town and Michael C. Heinrich. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Clinical Cancer Research, Blood and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.